Gain and loss of abilities in type II SMA: A 12-month natural history study-Reference-Cited by-同舟云学术

Gain and loss of abilities in type II SMA: A 12-month natural history study

Published:2020-09 Issue:9 Volume:30 Page:765-771
ISSN:0960-8966
Container-title:Neuromuscular Disorders
language:en
Short-container-title:Neuromuscular Disorders

Author:

Coratti Giorgia,Lucibello Simona,Pera Maria C,Duong Tina,Muni Lofra Robert,Civitello Matthew,D'Amico Adele,Goemans Nathalie,Darras Basil T,Bruno Claudio,Sansone Valeria A,Day John,Nascimento Osorio Andres,Muntoni Francesco,Montes Jaccqueline,Sframeli Maria,Finkel Richard,Mercuri Eugenio

Publisher

Elsevier BV

Subject

Genetics (clinical),Neurology (clinical),Neurology,Pediatrics, Perinatology and Child Health

Reference12 articles.

1. The Hammersmith functional motor scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation;Main;Eur J Paediatr Neurol,2003

2. An expanded version of the hammersmith functional motor scale for SMA II and III patients;O'Hagen;Neuromuscul Disord,2007

3. Patterns of disease progression in type 2 and 3 SMA: implications for clinical trials;Mercuri;Neuromuscul Disord,2016

4. Categorising trajectories and individual item changes of the north star ambulatory assessment in patients with Duchenne muscular dystrophy;Muntoni;PLoS ONE,2019

5. Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial;McDonald;Lancet,2017

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of Nusinersen in Adolescents and Adults with Spinal Muscular Atrophy: Systematic Review and Meta-analysis;Neurology and Therapy;2024-09-02

2. Changes in abilities over the initial 12 months of nusinersen treatment for type II SMA;Neuromuscular Disorders;2024-08

3. Exploring functional strength changes during nusinersen treatment in symptomatic children with SMA types 2 and 3.;Neuromuscular Disorders;2024-08

4. Upper limb function changes over 12 months in untreated SMA II and III individuals: an item-level analysis using the Revised Upper Limb Module;Neuromuscular Disorders;2024-08

5. Effects of nusinersen on motor function in children with spinal muscular atrophy: a retrospective study;Frontiers in Neurology;2024-07-15